Position in KRYS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$4,518,020
+$1,409,914 QoQ
Shares Held
12,156
+1.0% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#120
of 422 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Torray Investment Partners LLC holds $61,710,475 across 8 Biotechnology names. KRYS ranks #3 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
602,028 | $33,755,709 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,215 | $7,557,746 | |
| 3 | KRYS |
Krystal Biotech, Inc.
This page
|
12,156 | $4,518,020 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
77,705 | $4,446,280 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
14,928 | $3,653,926 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
38,703 | $3,029,283 | |
| 7 | SNDX |
Syndax Pharmaceuticals Inc
|
133,835 | $2,925,633 | |
| 8 | VSTM |
Verastem, Inc.
|
477,455 | $1,823,878 |
All Filings in KRYS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,518,020 | 12,156 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $3,108,106 | 12,032 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $2,954,781 | 11,985 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $2,100,883 | 11,901 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,590,962 | 11,574 | Shares | Sole | 2025-08-05 | |
| No filing history on record for this holder in this stock. | ||||||